BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11085753)

  • 1. Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
    Hancock WW; Lu B; Gao W; Csizmadia V; Faia K; King JA; Smiley ST; Ling M; Gerard NP; Gerard C
    J Exp Med; 2000 Nov; 192(10):1515-20. PubMed ID: 11085753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
    Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
    J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived IP-10 initiates development of acute allograft rejection.
    Hancock WW; Gao W; Csizmadia V; Faia KL; Shemmeri N; Luster AD
    J Exp Med; 2001 Apr; 193(8):975-80. PubMed ID: 11304558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.
    Miura M; Morita K; Kobayashi H; Hamilton TA; Burdick MD; Strieter RM; Fairchild RL
    J Immunol; 2001 Sep; 167(6):3494-504. PubMed ID: 11544343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
    Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
    J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.
    Zhang Z; Kaptanoglu L; Tang Y; Ivancic D; Rao SM; Luster A; Barrett TA; Fryer J
    Gastroenterology; 2004 Mar; 126(3):809-18. PubMed ID: 14988835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts.
    Fahmy NM; Yamani MH; Starling RC; Ratliff NB; Young JB; McCarthy PM; Feng J; Novick AC; Fairchild RL
    Transplantation; 2003 Jun; 75(12):2044-7. PubMed ID: 12829909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection.
    Panzer U; Reinking RR; Steinmetz OM; Zahner G; Sudbeck U; Fehr S; Pfalzer B; Schneider A; Thaiss F; Mack M; Conrad S; Huland H; Helmchen U; Stahl RA
    Transplantation; 2004 Nov; 78(9):1341-50. PubMed ID: 15548973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft.
    Li B; Xu W; Xu L; Jiang Z; Wen Z; Li K; Xiong S
    Cell Immunol; 2010; 260(2):83-91. PubMed ID: 19875106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CXCR3 and CCR5 in allograft rejection.
    Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft.
    Jiankuo M; Xingbing W; Baojun H; Xiongwin W; Zhuoya L; Ping X; Yong X; Anting L; Chunsong H; Feili G; Jinquan T
    J Immunol; 2003 Feb; 170(3):1556-65. PubMed ID: 12538721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
    Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
    J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
    Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
    J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
    Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
    J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.
    Melter M; Exeni A; Reinders ME; Fang JC; McMahon G; Ganz P; Hancock WW; Briscoe DM
    Circulation; 2001 Nov; 104(21):2558-64. PubMed ID: 11714650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.
    Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB
    Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
    Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
    Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Zisman DA; Xue YY; Li K; Ardehali A; Ross DJ; Strieter RM
    J Immunol; 2003 Nov; 171(9):4844-52. PubMed ID: 14568964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
    Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
    Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.